Analysis reveals TIAM2 overexpression correlates with tumor multiplicity and poor prognosis in hepatocellular carcinoma, suggesting it as a therapeutic target.
TIAM2 overexpression closely correlated with tumor multiplicity and poor prognosis in resected HCC, thus being a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: